Pyrosequencing method for sensitive detection of HBV drug resistance mutations

Journal of Medical Virology
Guan-Huei LeeSeng-Gee Lim

Abstract

Hepatitis B (HBV) drug resistance assay is important for guiding therapy after the development of virologic breakthrough for patients receiving nucleoside/-tide analog therapy. However, the existing genotyping tools are either costly or lack sensitivity to detect mixed genotypes, and an improved method of resistant mutation detection is needed. An assay protocol for clinical application using pyrosequencing method was developed, capable of detecting all known validated HBV polymerase gene mutations that impart resistance to lamivudine, adefovir, tenofovir, and entecavir. Sixty-eight serum samples with known HBV resistance genotypes, previously tested with either Sanger sequencing assay or commercial line probe assay, were used for validation. Where there were discrepancies between the two methods, clonal sequencing by Sanger's method was used for confirmation. The modified pyrosequencing method accurately identified all the cloned polymerase genotypes and was able to distinguish as little as 5% of the mutant populations. This assay can be performed on serum sample with HBV DNA as low as 13.5 IU/mL. The cost per test was less than existing commercial assay. HBV drug resistance pyrosequencing assay was accurate, more sensitive an...Continue Reading

References

Aug 15, 1998·Science·M RonaghiP Nyrén
Jan 13, 2001·Genome Research·M Ronaghi
Oct 9, 2004·Journal of Clinical Microbiology·Anna LindströmJan Albert
Jun 29, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S LokUNKNOWN Hepatitis B Virus Drug Resistance Working Group
Apr 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marc G Ghany, Edward C Doo
Sep 22, 2009·Methods in Molecular Biology·Jose Luis Royo, Jose Jorge Galán
Jun 21, 2011·Antiviral Therapy·Paula TumaUNKNOWN CoRIS Study Group
Jan 27, 2012·Journal of Oral Microbiology·José F SiqueiraIsabela N Rôças
Jul 19, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ching-Lung Lai, Man-Fung Yuen
Jan 26, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Guan-Huei LeeSeng-Gee Lim

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.